CPE, China Life Investment Management and Fortune Capital led a $126m Series C funding round in SiBionics, a medtech firm, with participation from China Life, Qianhai FOF, C&D, JD Invesment, Jingming Capital, Lucion, Source Code Capital, Cedarlake Capital and Riverhead Capital.